← Eichor
Condition: Pfa Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Pfa

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

REPRESENT-PF Registry
Phase N/A · 2 location(s) · Vivek Reddy · NCT07535268LA Function After PFA in Paroxysmal AF
Phase N/A · 1 location(s) · Charles University, Czech Republic · NCT07439016Intra-abdominal Pressure (IAP) During PFA Treatment of A-fib/ A-Flutter
NA · 1 location(s) · Wake Forest University Health Sciences · NCT06876896Application-Based Integrated Care in Patients After Pulse Field Ablation
NA · 1 location(s) · Yonsei University · NCT07119528Implantation of Engineered Cartilage Grafts for Treatment of Patellofemoral Osteoarthritis Versus Surgical Comparators.
Phase 2 · 11 location(s) · University Hospital, Basel, Switzerland · NCT06576583Evaluation of Novel Waveforms Delivered Using the FARAPULSE™ PFA System
NA · 4 location(s) · Boston Scientific Corporation · NCT07444320A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants Wit
NA · 11 location(s) · Biosense Webster, Inc. · NCT07523750Feasibility Study of the FARAFLEX Mapping and PFA System
NA · 4 location(s) · Boston Scientific Corporation · NCT06510556NS-PFA Catheter Ablation of Paroxysmal Atrial Fibrillation With the Pulse Biosciences CellFX System
NA · 1 location(s) · Pulse Biosciences, Inc. · NCT07018596Ablation With the PFA System With a Large-Area Focal Catheter for the Treatment of Persistent Atrial Fibrillation
NA · 3 location(s) · CardioFocus · NCT07281521Multitarget Pulse Field Ablation Guided by Endocardial and Non-invasive Atrial Driver Mapping (PFA+ADM) Pilot Study. Dev
NA · 1 location(s) · Fundacion para la Innovacion en Biomedicina (FIBMED) · NCT07118488CellFX® Nanosecond Pulsed Field Ablation (PFA) 360 Catheter Ablation System for Treatment of Atrial Fibrillation
NA · 3 location(s) · Pulse Biosciences, Inc. · NCT06696170OPTION-EMEA Clinical Trial
NA · 3 location(s) · Boston Scientific Corporation · NCT07349121Target Validation and Efficacy of Metformin in Patients With Posterior Fossa Group A (PFA) Ependymoma
Phase 2 · 5 location(s) · University of California, San Francisco · NCT07226453Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sp
NA · 30 location(s) · Medtronic Cardiac Ablation Solutions · NCT07298473Pulmonary Vein Isolation With the Single Shot Endoscopic Ultra-Compliant PFA Balloon for the Treatment of AF
NA · 1 location(s) · CardioFocus · NCT06828939BaLloon-based PFA Ablation poST Approval Outcomes for PAF and PersAF
NA · 22 location(s) · Abbott Medical Devices · NCT07181590PulseSelect™ PFA Global Registry
Phase N/A · 37 location(s) · Medtronic Cardiac Ablation Solutions · NCT06393920The Potential Protective Effect of Using Muscle Relaxants During Electroporation Ablation (PFA)
NA · 1 location(s) · 4th Military Clinical Hospital with Polyclinic, Poland · NCT06707532Repeat Ablation of Persistent Atrial Fibrillation, Including Mitral Isthmus Catheter Ablation, With the FARAPULSE Pulsed
NA · 41 location(s) · Boston Scientific Corporation · NCT06735534Outcomes of PFA Vs. RFA for Patients with PSVT: a Retrospective and Propensity Score Matching Study
Phase N/A · 1 location(s) · Caijie Shen · NCT06573853PULSED AF Post-Approval Study
Phase N/A · 18 location(s) · Medtronic Cardiac Ablation Solutions · NCT06578104cOncomitant Left Atrial aPpendage Closure and Pulsed Field ablaTION-Asia
Phase N/A · 37 location(s) · Boston Scientific Corporation · NCT06686485PVI Alone Versus PVI Plus PWI and SVCI With PFA
NA · 1 location(s) · Edward Gerstenfeld, MD · NCT07405359Comparative Intra-procedural Evaluation of Farapulse and FARAWAVE Nav Catheters
NA · 1 location(s) · Cardiocentro Ticino · NCT07130773Repeatable Evaluation of Functional Intra-procedural Signals for Effect in Pulsed Field Ablation REFINE-PFA
Phase N/A · 2 location(s) · CathVision ApS · NCT07275151
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.